UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006086
Receipt No. R000007037
Scientific Title Efficacy and safety of Eribulin as the first line therapy for advanced or recurrent breast cancer patients without HER2 overexpression.
Date of disclosure of the study information 2011/07/31
Last modified on 2016/06/12 16:35:15

No. Disposal Last modified on Item of update
1 Insert 2011/07/31 19:48:44
2 Update 2011/09/27 11:15:16 Acronym
Acronym
3 Update 2011/09/27 11:15:49
4 Update 2012/03/06 12:57:02 Organization1
Address1
Tel1
Email1
5 Update 2014/11/24 15:55:13 Key inclusion criteria
6 Update 2014/11/24 15:57:27 Email
Last name of contact person
Last name of contact person
Address
7 Update 2014/11/24 16:00:44 Recruitment status
Last follow-up date
8 Update 2016/06/12 16:35:15 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
URL related to results and publications
Results


Contact us.